Breaking News Instant updates and real-time market news.

SYT

Syngenta

$91.85

-0.05 (-0.05%)

, BASFY

BASF

$96.62

2.15 (2.28%)

13:28
06/12/17
06/12
13:28
06/12/17
13:28

Syngenta, BASF among bidders for Bayer-Monsanto divestitures, Bloomberg says

Syngenta (SYT) and BASF (BASFY) are among companies that have submitted preliminary offers for assets that Bayer (BAYRY) plans to divest to secure approval for its acquisition of Monsanto (MON), Bloomberg reported, citing sources. The businesses include cottonseeds, canola, the LibertyLink herbicide-resistant trait, and the company's glufosinate weed killer, the sources told Bloomberg, adding that Bayer could also sell garlic and pepper seed businesses separately or as part of the total package. The divestitures could fetch $2.5B-$3B, the sources told the publication. Reference Link

SYT

Syngenta

$91.85

-0.05 (-0.05%)

BASFY

BASF

$96.62

2.15 (2.28%)

BAYRY

Bayer

MON

Monsanto

$117.59

0.07 (0.06%)

  • 12

    Jun

  • 13

    Jun

  • 26

    Jun

  • 28

    Jun

SYT Syngenta
$91.85

-0.05 (-0.05%)

09/06/16
BERN
09/06/16
DOWNGRADE
BERN
Market Perform
Syngenta downgraded on valuation, anticipated deal delay at Bernstein
As noted earlier, Bernstein downgraded Syngenta to Market Perform from Outperform. As reasons for the downgrade, analyst Jeremy Redenius cited valuation and his belief that regulatory approvals for the company's acquisition by ChemChina could be delayed until 2017. Target to $92.20 from $90.20.
12/09/16
RAJA
12/09/16
UPGRADE
RAJA
Strong Buy
Syngenta upgraded to Strong Buy from Outperform at Raymond James
Raymond James analyst Patrick Lambert upgraded Syngenta to Strong Buy.
03/03/17
JPMS
03/03/17
NO CHANGE
Target $128
JPMS
Overweight
EU approvals of other ag deals may narrow Monsanto deal spread, says JPMorgan
JPMorgan analyst Jeffrey Zekauskas said commentary from the CEOs of DuPont (DD) and Syngenta (SYT) and press reports from Europe suggest that their deals with Dow Chemical (DOW) and ChemChina, respectively, are likely to be approved. Approvals from Europe for those deals may "trigger a meaningful closing of the arbitrage spread" in Monsanto (MON) shares versus Bayer's (BAYRY) offer price, Zekauskas tells investors. He recommends buying Monsanto shares at current levels for this reason, adding that he believes the shares would only fall about 2.5%, or down to $112, in the event of the Bayer deal falling through. Zekauskas keeps an Overweight rating and $128 price target on Monsanto shares, which closed yesterday at just below $115 per share.
02/16/17
JEFF
02/16/17
DOWNGRADE
JEFF
Hold
Syngenta downgraded to Hold from Buy at Jefferies
Jefferies analyst Laurence Alexander downgraded Syngenta to Hold with an unchanged price target of CHF 445.
BASFY BASF
$96.62

2.15 (2.28%)

02/13/17
EVER
02/13/17
INITIATION
EVER
Buy
BASF initiated with a Buy at Evercore ISI
Evercore ISI analyst Laurent Favre initiated BASF with a Buy rating and a EUR100 price target.
01/19/17
JPMS
01/19/17
UPGRADE
JPMS
Overweight
BASF upgraded to Overweight from Underweight at JPMorgan
JPMorgan analyst Martin Evans yesterday double upgraded BASF to Overweight from Underweight saying he's turning more positive on European Chemicals.
10/05/16
UBSW
10/05/16
UPGRADE
UBSW
Buy
BASF upgraded to Buy from Neutral at UBS
07/14/16
JEFF
07/14/16
NO CHANGE
JEFF
Monsanto needs over $135/share bid to shut down alternatives, says Jefferies
After media reports indicated that Monsanto (MON) has revived talks with BASF (BASFY) as an alternative to the offer from Bayer (BAYRY), Jefferies analyst Laurence Alexander said he believes Bayer would need to increase its bid to over $135 per share for Monsanto to shut down its consideration of alternatives. The analyst views Bayer as "the best technology and market position fit for Monsanto," but adds that BASF "would have significantly less antitrust concerns."
BAYRY Bayer

04/10/17
PIPR
04/10/17
NO CHANGE
Target $17
PIPR
Overweight
OncoMed price target lowered to $17 from $26 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff lowered his price target for OncoMed (OMED) to $17 from $26 following two negative announcements, namely that the Phase II YOSEMITE study of demcizumab in first line pancreatic cancer failed and Bayer (BAYRY) returned rights for ipafricept and vantictumab. The analyst also notes that now partner Celgene (CELG) will review all data on demcizumab including Phase II DENALI non-small cell lung cancer data and Phase Ib combo data with KEYTRUDA, although he does not expect Celgene to exercise its option. Tenthoff reiterates an Overweight rating on OncoMed's shares.
04/06/17
JPMS
04/06/17
NO CHANGE
Target $128
JPMS
Overweight
Monsanto shares offer 'excellent' risk/reward proposition, says JPMorgan
JPMorgan analyst Jeffrey Zekauskas says shares of Monsanto (MON) at current levels offer an "excellent" risk/reward proposition. The analyst views capital appreciation potential to the end of 2017 as 11% or a 15% annual return. He sees downside risk of only 3%, to $112 per share, in the event that Bayer (BAYRY) is not able to consummate the acquisition. Zekauskas has increased confidence in the deal closing following recent regulatory rulings and keeps an Overweight rating on the name with a $128 price target.
01/06/17
JPMS
01/06/17
NO CHANGE
Target $128
JPMS
Overweight
Monsanto shares are mispriced, says JPMorgan
JPMorgan analyst Jeffrey Zekauskas says Monsanto (MON) shares are mispriced and offer an attractive risk/reward proposition. A first catalyst for the shares would be regulatory agreement in the Dow Chemical (DOW)/DuPont (DD) transaction, Zekauskas tells investors in a research note. The analyst thinks a favorable resolution to the Dow/DuPont merger would be seen as improving the probability of the success of the Bayer/Monsanto transaction. He notes that Bayer has agreed to purchase Monsanto for $128 per share in cash, which represents 21% appreciation potential should the deal close by year-end. Zekauskas thinks a "reasonable floor" price for Monsanto shares, should the deal fail, is $102. He keeps an Overweight rating on the name with a $128 price target.
MON Monsanto
$117.59

0.07 (0.06%)

02/23/17
02/23/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Monsanto (MON) initiated with a Sector Perform at RBC Capital. 2. FMC Corporation (FMC) initiated with an Outperform at RBC Capital. 3. OncoCyte (OCX) initiated with a Buy at Chardan. 4. Jazz Pharmaceuticals (JAZZ) initiated with a Buy at Evercore ISI. 5. Reata Pharmaceuticals (RETA) initiated with a Buy at Stifel. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/23/17
RBCM
02/23/17
INITIATION
RBCM
Sector Perform
Monsanto initiated with a Sector Perform at RBC Capital
RBc Capital analyst Arun Viswanathan says that ,"given challenging agricultural conditions, Monsanto lacks catalysts. Target $118.

TODAY'S FREE FLY STORIES

ENSV

Enservco

$0.65

0.0196 (3.11%)

07:01
11/21/17
11/21
07:01
11/21/17
07:01
Hot Stocks
Enservco enters into agreement with bank 

Enservco

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSW

DSW

$22.53

0.38 (1.72%)

07:00
11/21/17
11/21
07:00
11/21/17
07:00
Earnings
DSW reports Q3 adjusted EPS 45, consensus 53c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

SIG

Signet Jewelers

$75.84

-0.74 (-0.97%)

07:00
11/21/17
11/21
07:00
11/21/17
07:00
Earnings
Signet Jewelers lowers FY18 EPS view to $6.10-$6.50 from $7.16-$7.56 »

Consensus $7.02. Lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 07

    Dec

  • 08

    Dec

RXDX

Ignyta

$15.75

0.85 (5.70%)

07:00
11/21/17
11/21
07:00
11/21/17
07:00
Initiation
Ignyta initiated  »

Ignyta initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

LSI

Life Storage

$87.95

-0.73 (-0.82%)

07:00
11/21/17
11/21
07:00
11/21/17
07:00
Upgrade
Life Storage rating change  »

Life Storage upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SC

Santander Consumer

$17.07

0.75 (4.60%)

06:59
11/21/17
11/21
06:59
11/21/17
06:59
Recommendations
Santander Consumer analyst commentary  »

Santander Consumer added…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

06:59
11/21/17
11/21
06:59
11/21/17
06:59
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRIX

IRIDEX

$7.63

-0.09 (-1.17%)

06:59
11/21/17
11/21
06:59
11/21/17
06:59
Conference/Events
IRIDEX management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

SIG

Signet Jewelers

$75.84

-0.74 (-0.97%)

06:58
11/21/17
11/21
06:58
11/21/17
06:58
Earnings
Signet Jewelers now sees FY18 EPS $6.10-$6.50, consensus $7.02 »

Signet CEO Virginia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 07

    Dec

  • 08

    Dec

GDX

Market Vector Gold Miners

$22.54

-0.25 (-1.10%)

06:58
11/21/17
11/21
06:58
11/21/17
06:58
Technical Analysis
Market Vector Gold Miners: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$121.31

-1.55 (-1.26%)

06:58
11/21/17
11/21
06:58
11/21/17
06:58
Technical Analysis
SPDR Gold Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUGT

Direxion Gold Miners Bull

$28.92

-0.88 (-2.95%)

06:57
11/21/17
11/21
06:57
11/21/17
06:57
Technical Analysis
Direxion Gold Miners Bull: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIG

Signet Jewelers

$75.84

-0.74 (-0.97%)

06:57
11/21/17
11/21
06:57
11/21/17
06:57
Earnings
Signet Jewelers reports Q3 EPS with items (20c), consensus 10c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 07

    Dec

  • 08

    Dec

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$14.70

-0.82 (-5.28%)

06:57
11/21/17
11/21
06:57
11/21/17
06:57
Technical Analysis
Direxion Daily Jr Gld Mnrs Bull 3X Shrs: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZN

Horizon Global

$14.38

0.49 (3.53%)

06:57
11/21/17
11/21
06:57
11/21/17
06:57
Conference/Events
Horizon Global management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

DUST

Direxion Daily Gold Miners Bear 3X ETF

$27.02

0.93 (3.56%)

06:56
11/21/17
11/21
06:56
11/21/17
06:56
Technical Analysis
Direxion Daily Gold Miners Bear 3X ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HK

Halcon Resources

$7.12

0.08 (1.14%)

06:56
11/21/17
11/21
06:56
11/21/17
06:56
Conference/Events
Halcon Resources management to meet with Imperial Capital »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 15

    May

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$65.13

3.43 (5.56%)

06:56
11/21/17
11/21
06:56
11/21/17
06:56
Technical Analysis
Direxion Daily Junior Gold Miners Index Bear 3x Shares: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBIN

Merchants Bancorp

$17.68

0.05 (0.28%)

06:55
11/21/17
11/21
06:55
11/21/17
06:55
Initiation
Merchants Bancorp initiated  »

Merchants Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBIN

Merchants Bancorp

$17.68

0.05 (0.28%)

06:55
11/21/17
11/21
06:55
11/21/17
06:55
Initiation
Merchants Bancorp initiated  »

Merchants Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VXX

iPath S&P 500 VIX Short-Term Futures

$33.36

-1.09 (-3.16%)

06:55
11/21/17
11/21
06:55
11/21/17
06:55
Technical Analysis
iPath S&P 500 VIX Short-Term Futures: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$264.57

2.35 (0.90%)

06:55
11/21/17
11/21
06:55
11/21/17
06:55
Recommendations
Boeing analyst commentary  »

Boeing free cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XIV

VelocityShares Daily Inverse VIX Short-Term ETN

$113.09

3.39 (3.09%)

06:54
11/21/17
11/21
06:54
11/21/17
06:54
Technical Analysis
VelocityShares Daily Inverse VIX Short-Term ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TVIX

VelocityShares Daily 2x VIX Short-Term ETN

$8.05

-0.54 (-6.29%)

06:54
11/21/17
11/21
06:54
11/21/17
06:54
Technical Analysis
VelocityShares Daily 2x VIX Short-Term ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAG

MAG Silver

$10.98

-0.07 (-0.63%)

06:54
11/21/17
11/21
06:54
11/21/17
06:54
Downgrade
MAG Silver rating change  »

MAG Silver downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.